GPAS-wrapup-header---EN

Second GPAS brings stakeholders together to help improve access

On October 27 and 28, 2022, the World Federation of Hemophilia (WFH) held the second edition of the Global Policy and Access Summit (GPAS). The two-day virtual event was dedicated to promoting dialogue and knowledge-sharing to identify strategies for sustaining and advancing bleeding disorders care in the fast-changing pandemic world. The event’s goal was to help the community get a step closer to making sustainable care possible for people with bleeding disorders (PWBDs) everywhere.

Also available in: Français Español

The program for the second edition of the WFH GPAS included plenaries, educational sessions, and lightning round presentations of NMO advocacy initiatives from all over the world. Over the course of the event, successes and lessons learned were shared. The first day of the summit focused on the policy environment and explored strategies for participating in healthcare decision making. The second day of the event mostly centred around inequities in access to treatment and care, and strategies for approaching this challenge in an era of therapeutic advancements. The second day also included a WFH highlight session featuring the WFH PACT Advocacy Academy—including the first-year results from the course—as well as advocacy campaigns shared by course graduates.

To take part in the GPAS is to join a team of like-minded people with passion. Passion to get together and work in a constructive way to find solutions for sustaining and advancing bleeding disorders care. It was inspirational to see everyone working together for a common good.

—Cesar Garrido, President, WFH

Smaller group stakeholder discussions were held on both days, centred around the issues of shared decision-making, influencing health policy, increasing sustainable access to treatment through evidence-based advocacy, and optimizing procurement mechanisms and processes. The main takeaways from the stakeholder group discussions were presented at the closing plenary.

The event brought together 419 participants from nearly 100 countries, including WFH national member organizations (NMOs) staff and volunteers, healthcare providers, representatives of national government institutions, industry partners, international agencies, and other collaborating organizations.

All GPAS plenary and educational sessions can be viewed on demand at the GPAS online platform in English, French, Spanish, Russian and Arabic until December 28, 2022.  To view the sessions, click here.

The WFH would like to thank the GPAS program committee for their hard work that made this important event possible: Cesar Garrido, President, WFH; Dawn Rotellini, Lay Member, WFH Board of Directors; Ekawat Suwantaroj, Lay Member, WFH Board of Directors; Megan Adediran, Lay Member, WFH Board of Directors; Clive Smith, Chair of the Board, The Haemophilia Society; Declan Noone, President, European Haemophilia Consortium; Juan Andrés Pereira de Souza, Asociación De Hemofilia Del Uruguay; Miguel Crato, Member, European Haemophilia Consortium; and Bradley Rayner, Chairman, South African Haemophilia Foundation.

The second edition of the WFH Global Policy and Access Summit (GPAS) is supported by funding from the Hemophilia Alliance and its member hemophilia treatment centres (HTCs) across the U.S.A.

Hemophilia Alliance logo

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.